Analgesia and curative effect of pamidronate disodium combined with chemotherapy on elderly patients with advanced metastatic bone cancer
Open Access
- 10 May 2019
- journal article
- research article
- Published by Spandidos Publications in Oncology Letters
- Vol. 18 (1), 771-775
- https://doi.org/10.3892/ol.2019.10340
Abstract
The curative effect and adverse reactions of pamidronate disodium in elderly patients with advanced metastatic bone cancer were evaluated. A total of 160 elderly patients with advanced metastatic bone cancer admitted to Affiliated Hospital of Nantong University from February 2012 to January 2015, were divided into the chemotherapy group (n=60) that received routine therapy and the pamidronate disodium group (n=100) that received pamidronate disodium therapy based on the chemotherapy. Pain relief, analgesic time, analgesic duration and side effects were compared between the two groups after treatment. The effect of pain relief in the pamidronate disodium group was significantly higher than that in the chemotherapy group (P<0.001). The total effective rate of the pamidronate disodium group was significantly higher than that of the chemotherapy group (P<0.001). The analgesic onset time in the pamidronate disodium group was earlier than in the chemotherapy group (P<0.001). The analgesic duration in the pamidronate disodium group was longer than that in the chemotherapy group (P<0.001). The incidence of adverse reactions and complications after treatment in the pamidronate disodium group was significantly less than that in the chemotherapy group (P<0.001). The results indicated that pamidronate disodium is effective in the treatment of elderly patients with advanced metastatic bone cancer and patients are less prone to adverse reactions, complications and pain, which is worthy of clinical application.Keywords
This publication has 28 references indexed in Scilit:
- Targeting bone metastases in prostate cancer: improving clinical outcomeNature Reviews Urology, 2015
- ANGPTL2 increases bone metastasis of breast cancer cells through enhancing CXCR4 signalingScientific Reports, 2015
- Transforming growth factor-β promotes prostate bone metastasis through induction of microRNA-96 and activation of the mTOR pathwayOncogene, 2014
- The critical role of bisphosphonates to target bone cancer metastasis: an overviewJournal of Drug Targeting, 2014
- Studies Comparing Numerical Rating Scales, Verbal Rating Scales, and Visual Analogue Scales for Assessment of Pain Intensity in Adults: A Systematic Literature ReviewJournal of Pain and Symptom Management, 2011
- Denosumab Compared With Zoledronic Acid for the Treatment of Bone Metastases in Patients With Advanced Breast Cancer: A Randomized, Double-Blind StudyJournal of Clinical Oncology, 2010
- Effect of bisphosphonates on pain and quality of life in patients with bone metastasesNature Reviews Clinical Oncology, 2009
- Biology of Bone Cancer PainClinical Cancer Research, 2006
- Bisphosphonates for the relief of pain secondary to bone metastasesEmergencias, 2002
- Intravenous pamidronate disodium treatment of bone metastases in patients with breast cancer. A dose-seeking studyCancer, 1994